PTC Therapeutics, Inc. (PTCT)
64.70
+2.14
(+3.42%)
USD |
NASDAQ |
Oct 09, 16:00
64.70
0.00 (0.00%)
After-Hours: 20:00
PTC Therapeutics Gross Profit Margin (Quarterly) : 91.19% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 91.19% |
| March 31, 2026 | 85.47% |
| December 31, 2025 | 90.10% |
| September 30, 2025 | 88.95% |
| June 30, 2025 | 91.35% |
| March 31, 2025 | 98.58% |
| December 31, 2024 | 90.81% |
| September 30, 2024 | 92.94% |
| June 30, 2024 | 90.15% |
| March 31, 2024 | 68.46% |
| December 31, 2023 | 65.38% |
| September 30, 2023 | 65.34% |
| June 30, 2023 | 71.88% |
| March 31, 2023 | 75.70% |
| December 31, 2022 | 72.13% |
| September 30, 2022 | 79.26% |
| June 30, 2022 | 78.29% |
| March 31, 2022 | 77.40% |
| December 31, 2021 | 84.47% |
| September 30, 2021 | 84.92% |
| June 30, 2021 | 82.77% |
| March 31, 2021 | 82.72% |
| December 31, 2020 | 86.99% |
| September 30, 2020 | 87.93% |
| June 30, 2020 | 81.35% |
| Date | Value |
|---|---|
| March 31, 2020 | 82.37% |
| December 31, 2019 | 88.06% |
| September 30, 2019 | 85.95% |
| June 30, 2019 | 88.56% |
| March 31, 2019 | 84.22% |
| December 31, 2018 | 88.62% |
| September 30, 2018 | 83.05% |
| June 30, 2018 | 88.12% |
| March 31, 2018 | 84.89% |
| December 31, 2017 | 89.92% |
| September 30, 2017 | 73.01% |
| June 30, 2017 | 98.42% |
| March 31, 2017 | 99.85% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 0.00% |
| March 31, 2014 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | 61.37% |
| BioMarin Pharmaceutical, Inc. | 72.27% |
| Arcturus Therapeutics Holdings, Inc. | 31.82% |
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -1.34% |
| Return on Invested Capital | -13.96% |
| Profit Margin (Quarterly) | 23.16% |
| Operating Margin (Quarterly) | 41.32% |
| Return on Net Operating Assets | -4.56% |